中国—东盟中药鲜药保健品产业发展策略探讨  

Discussion on Development Strategy of ASEAN-China Fresh Herbs Health Products Industry

作　　者：胡小勤[1] 付蓉 李莉[1] 王菲菲 曾学文[1] HU Xiao-qin;FU Rong;LI li;WANG Fei-fei;ZENG Xue-wen(Guangxi University of Chinese Medicine,Nanning 530001,China)

机构地区：[1]广西中医药大学,广西南宁530001

出　　处：《中国现代中药》2020年第1期134-137,共4页Modern Chinese Medicine

基　　金：中国—东盟传统医药发展研究中心资助课题(0501906414)。

摘　　要：为了更好地促进中药鲜药保健品产业发展,本研究拟选取中国—东盟共有的传统药物作为原料药材,以鲜药为应用形式,在中医药理论指导下探讨中药鲜药保健品产业发展策略。发展中国—东盟中药鲜药保健品产业,既具有现实的必要性,又具有实践的可行性。本研究制定了实施策略和具体的实施办法,以期能为产业实际提供指导,对促进中药鲜药保健品产业发展具有重要的科学意义、社会意义和经济价值。In order to better promote the development of traditional Chinese medicine fresh medicine and health products industry,we select the traditional Chinese medicine shared by ASEAN-China as the raw materials,take fresh medicine as the application form,and under the guidance of traditional Chinese medicine theory,explore the development strategy of traditional Chinese medicine fresh medicine and health products industry.It is not only necessary but also feasible to develop ASEAN-China fresh medicine health care industry.We have formulated implementation strategies and specific implementation methods,which can provide guidance for the industry's actuality,and have important scientific,social and economic value.

关 键 词：中国—东盟 中药鲜药 保健品 

分 类 号：F752.65[经济管理—国际贸易] R282.7[经济管理—产业经济]